Sanofi investing €350 million for new vaccine factory in Canada
Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…
Pharmaceuticals, Biotechnology and Life Sciences
Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…
The European Medicines Agency (EMA) has accepted for review Sanofi’s regulatory submission for oral treatment sotagliflozin, developed in partnership with…
Evotec and Sanofi have entered exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform, the companies said…
Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…
Sanofi has asked the European Medicines Agency (EMA) to review fexinidazole for the treatment of sleeping sickness. Fexinidazole is being…
Sanofi will buy Belgian Nanobody technology specialist Ablynx for €3.9 billion, it was announced Monday by both companies.
Sanofi will buy Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, for $11,6…
STADA Arzneimittel AG is advancing the internationalization of its OTC brand business. On January 12, 2018, the company reached an…
Sanofi and Regeneron Pharmaceuticals said they will accelerate and expand investment for the clinical development of the PD-1 (programmed cell…
While physically over-the-counter (OTC) medicine packaging may mirror the prescription drug market, with continued strong demand for plastic primary pharmaceutical…